TT
TenNor Therapeutics focuses on the research and development of novel pharmacological agents targeting digestive diseases, utilizing advanced drug discovery techniques and preclinical models. The company aims to improve treatment outcomes for patients suffering from conditions such as inflammatory bowel disease and gastrointestinal disorders.
Updated 2 months ago
Funding
$42.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AAZVFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- TenNor Therapeutics focuses on the research and development of novel pharmacological agents targeting digestive diseases, utilizing advanced drug discovery techniques and preclinical models. The company aims to improve treatment outcomes for patients suffering from conditions such as inflammatory bowel disease and gastrointestinal disorders.